Kodiak Sciences Inc.
PALO ALTO, CA · Founded 2009 · CIK 0001468748 · Biotech · Public
Biologic therapeutics for retinal diseases, delivered via intravitreal injection
kodiak.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $36M
- 2 Form D · Mar 2016
- 127 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 14 granted · 26 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2008201020122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,836,044 | |
| Private capital raised | Form D · SEC | $33,960,000 |
Form D · SECPress
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1205 | ADIAL PHARMACEUTICALS, INC. | — | $38M |
| 1206 | FORWARD DEFENSE, LLC | — | — |
| 1207 | Gigagen, Inc. | — | $36M |
| 1208 | Kodiak Sciences Inc. | — | $36M |
| 1209 | MIRNATECH INTERNATIONAL, INC. | — | — |
| 1210 | VIVASC THERAPEUTICS INC | — | — |
| 1211 | AUGMENTA BIOWORKS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Press
3 Small-Cap Biotechs With Binary Catalysts on the CalendarMarketBeat
Founders & Team
- John BorgesonExecutive Officer
- Steven CharlesDirector · Executive Officer
- Victor PerlrothDirector · Executive Officer
Patents
- Methods Of Treating An Eye Disorderapplication
- Organic Compounds As NLRP3 Inhibitorsapplication
- Methods Of Treating An Eye Disordergranted
- Method Of Concentrating A Solution Or Formulationapplication
- NLRP3 Inhibitorsapplication
- Complement Factor D Antagonist Antibodies And Conjugates Thereofgranted
- Factor Viii Zwitterionic Polymer Conjugatesgranted
- IL-6 Antibodies And Fusion Constructs And Conjugates Thereofapplication
- High Molecular Weight Zwitterion-containing Polymersapplication
- IL-6 Antibodies And Fusion Constructs And Conjugates Thereofgranted
- Methods Of Treating An Eye Disorderapplication
- Use Of IL-6 Antibodies And Vegf Traps, And Fusion Constructs And Conjugates Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.